Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan P Schneider

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|December 6, 2024
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinomaAhmed Bilal Khalid, Christos Fountzilas, Heather N Burney, et al.
Breast Cancer Research and Treatment|April 13, 2017
Discerning the clinical relevance of biomarkers in early stage breast cancerTarah J Ballinger, Nawal Kassem, Fei Shen, et al.
JCO Precision Oncology|January 20, 2022
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer TherapyBryan P Schneider, Leigh Anne Stout, Santosh Philips, et al.
Scientific Reports|April 16, 2025
Association of heightened host and tumor immunity with prolonged duration of response to checkpoint inhibition across solid tumorsSantosh Philips, Pei Lu, Chris Fausel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Triple-negative breast cancer: risk factors to potential targetsBryan P Schneider, Eric P Winer, William D Foulkes, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2019
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for OncologyMarelize Swart, Wesley M Stansberry, Victoria M Pratt, et al.
British Journal of Cancer|December 2, 2015
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)Bryan P Schneider, Anne O'Neill, Fei Shen, et al.
Journal of Adolescent and Young Adult Oncology|July 1, 2026
Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Adolescent Young AdultsJennifer A Belsky, Allie Carter, Michael E Roth, et al.
Breast Cancer Research and Treatment|June 25, 2017
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?Ann H Partridge, Karen Sepucha, Anne O'Neill, et al.
Clinical Breast Cancer|October 6, 2010
Compliance differences between patients with breast cancer in university and county hospitalsIan K Komenaka, Robert E Pennington, Bryan P Schneider, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|December 6, 2024
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinomaAhmed Bilal Khalid, Christos Fountzilas, Heather N Burney, et al.
Breast Cancer Research and Treatment|April 13, 2017
Discerning the clinical relevance of biomarkers in early stage breast cancerTarah J Ballinger, Nawal Kassem, Fei Shen, et al.
JCO Precision Oncology|January 20, 2022
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer TherapyBryan P Schneider, Leigh Anne Stout, Santosh Philips, et al.
Scientific Reports|April 16, 2025
Association of heightened host and tumor immunity with prolonged duration of response to checkpoint inhibition across solid tumorsSantosh Philips, Pei Lu, Chris Fausel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Triple-negative breast cancer: risk factors to potential targetsBryan P Schneider, Eric P Winer, William D Foulkes, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2019
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for OncologyMarelize Swart, Wesley M Stansberry, Victoria M Pratt, et al.
British Journal of Cancer|December 2, 2015
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)Bryan P Schneider, Anne O'Neill, Fei Shen, et al.
Journal of Adolescent and Young Adult Oncology|July 1, 2026
Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Adolescent Young AdultsJennifer A Belsky, Allie Carter, Michael E Roth, et al.
Breast Cancer Research and Treatment|June 25, 2017
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?Ann H Partridge, Karen Sepucha, Anne O'Neill, et al.
Clinical Breast Cancer|October 6, 2010
Compliance differences between patients with breast cancer in university and county hospitalsIan K Komenaka, Robert E Pennington, Bryan P Schneider, et al.
Pageof 12